A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
PHASE1
The purpose of the study is to evaluate glofitamab + gemcitabine + oxalipla...
A Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Risk Patients With Diffuse Large B Cell Lymphoma (DLBCL)
PHASE1
This is an open label, multi-centre, phase Ib/II, parallel arm study evalua...
A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
PHASE3
This study will evaluate the efficacy and safety of glofitamab in combinati...
A Study Evaluating the Safety and Efficacy of Glofitamab or Mosunetuzumab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and High-Grade Large B-Cell Lymphoma
PHASE1
This study is designed to evaluate the safety and efficacy of glofitamab or...
Double-T - Improving Outcomes in High-risk 2nd Line Relapsed/Refractory Large B-Cell Lymphoma Patients Eligible for CAR-T-cell Therapy With a Glofitamab-based Induction and Consolidation Concept
PHASE2
The Double-T trial is a prospective, randomized, single-arm, open-label, mu...
Status
Not Yet Recruiting
Location
Universitätsklinikum Heidelberg - Innere Medizin V
A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
PHASE1
The purpose of this study is to evaluate the safety and efficacy of glofita...